Search results for: Mental Health
Filter search results
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
1 December 2021
…the best use to be made of the drug. If payers refuse to reimburse new treatments on the grounds of lack of good evidence of incremental effectiveness, there is likely…
Grace Hampson
28 May 2014
Grace is an economist with a strong interest in value assessment, pricing and reimbursement, and public health economics. She is team leader for OHE’s Policy, Organisation and Incentives in Health…
Nadine Henderson
26 September 2019
…environmental sustainability of the pharmaceutical industry and health systems. Her projects in this area include supporting the era of green pharmaceuticals in the UK and estimating the health and cost…
Supporting the Era of Green Pharmaceuticals in the UK
1 November 2022
…the challenge of reducing the NHS’s carbon footprint. Share this: Download publication Tackling the climate crisis is an international priority. Healthcare has a high carbon footprint, accounting for 5% of…
Raoh-Fang Pwu
15 May 2023
…She completed her training as an epidemiologist at the College of Public Health, National Taiwan University, where she developed expertise in research designs and the analysis of large/claims databases early…
Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
11 July 2023
…the discussion around dementia policy high in political agendas. Particularly, policies addressing the unmet needs of people living with dementia and a framework supporting informal carers both mentally and financially should be…
Alastair Fischer
30 August 2023
…have been in ambulance economics, economics of diagnosis and the methodology involved in evaluating the prevention of ill-health. He left NICE in 2016 to become Principal Health Economist at OHE…
OHE at ISPOR Europe 2023
13 November 2023, 12:00am
…Frederick McElwee Poster time: 10:30-13:30 Discussion period: 12:30-13:30 Poster Session Health Technology Assessment of Multiple Myeloma Therapies: Value Demonstration and Value Recognition Challenges Nadine Henderson Poster time: 10:30-13:30 Discussion period:…
Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective
2 November 2023
…or dialogue to enable developers (and thus investors) to predict how their product may perform against the scoring criteria. Replace wide value bands with smaller more incremental value bands to…